Neo 2 transcatheter heart valve system: Direct towards a minimalistic procedure
Transcatheter aortic valve replacement (TAVR) has expanded dramatically over the last two decades fueled by the results of multiple clinical trials demonstrating that TAVR is at least non-inferior to surgery for the treatment of patients with symptomatic severe aortic stenosis across the whole range of surgical risks [1].
Source: International Journal of Cardiology - Category: Cardiology Authors: Alberto Alperi, Isaac Pascual, Cesar Moris, Pablo Avanzas Tags: Editorial Source Type: research
More News: Aortic Stenosis | Cardiology | Clinical Trials | Heart | Heart Valve Disease | Heart Valve Surgery | Heart Valves